Acorah Software Products - Accounts Production 19.3.550 false true false true No description of principal activity 13 December 2024 31 December 2025 31 December 2025 16134941 Mr Adedapo Amoo iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16134941 2024-12-12 16134941 2025-12-31 16134941 2024-12-13 2025-12-31 16134941 frs-core:CurrentFinancialInstruments 2025-12-31 16134941 frs-bus:PrivateLimitedCompanyLtd 2024-12-13 2025-12-31 16134941 frs-bus:FilletedAccounts 2024-12-13 2025-12-31 16134941 frs-bus:Micro-entities 2024-12-13 2025-12-31 16134941 frs-bus:AuditExempt-NoAccountantsReport 2024-12-13 2025-12-31 16134941 frs-bus:Director1 2024-12-13 2025-12-31
Registered number: 16134941
Rex Healthcare Ltd
Unaudited Financial Statements
For the Period 13 December 2024 to 31 December 2025
Balance Sheet
Registered number: 16134941
31 December 2025
£
Current assets 6,002
Creditors: Amounts Falling Due Within One Year (1,043 )
NET CURRENT ASSETS 4,959
TOTAL ASSETS LESS CURRENT LIABILITIES 4,959
Accruals and deferred income (299 )
NET ASSETS 4,660
CAPITAL AND RESERVES 4,660

Notes

1. General Information
Rex Healthcare Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16134941 . The registered office is 34 Firth Crescent, Maltby, Rotherham, S66 7HS.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Adedapo Amoo
Director
27th August 2026